Traditional delivery in experimental settings has relied heavily on parenteral routes to circumvent gastrointestinal breakdown
83% of peptide-aware Americans want the FDA to make peptides more accessible Days before an FDA advisory committee meets to consider whether seven widely used peptides BPC-157, TB-500, KPV, MOTS-c, Emideltide (DSIP), Semax, and Epitalon should become eligible for compounding, a new survey suggests thats what Americans want
Clinical use: Effective against chronic infections, Lyme disease, mold toxicity, and biofilm-associated conditions
In practice the studies are small, the protocols are inconsistent, and the drug doesn't politely stay where it's injected, it still reaches the bloodstream